Novel antitumoral use of cabazitaxel

Details Novel antitumoral use of cabazitaxel Novel antitumoral use of cabazitaxel

Category

A - Human Necessities

Subcategory

61

Subsubcategory

K

IPC codes

A61K 31/337 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) A61K 31/573 (2006.01)

Type

Patent

Patent number

CA 2708489

Description

The invention relates to an antitumoral pharmaceutical combination comprising cabazitaxel of formula: (see above formula) and prednisone or prednisolone, these two agents possibly being in base form, or in the form of a hydrate or a solvate, intended for treating metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.

Affiliated with

Also associated with

Rating

Novel antitumoral use of cabazitaxel does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel antitumoral use of cabazitaxel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel antitumoral use of cabazitaxel will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1931800